SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Scripts who wrote (1150)1/10/2001 11:32:47 AM
From: tuck  Respond to of 1321
 
Ed & Ian,

This is not a near-term threat, so I don't know if it's behind the recent break of support, but it is a threat:

biz.yahoo.com

Cheers, Tuck



To: Scripts who wrote (1150)1/10/2001 11:39:26 AM
From: Ian@SI  Read Replies (1) | Respond to of 1321
 
Ed,

A short seller was a guest on CBC's Newsworld business program last night spreading misinformation about QLT's growth.

IMO, reimbursement issues will continue to get resolved. Visudyne will continue to be the most successful product in this sector; and ultimately QLT's stock price will again reflect this fact.

Ian.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News